Author Disclosures: C. Abraham: Nothing to disclose; A. Chopra: Nothing to disclose; E. Jung: Nothing to disclose; G. Landry: Nothing to disclose; T. Liem: Nothing to disclose; E. Mitchell: Nothing to disclose; G. Moneta: Nothing to disclose. Objectives: Initial data on drug-eluting stents (DES) shows they may increase durability of endovascular treatment of superficial femoral artery (SFA) disease compared to traditional bare-metal stents (BMS). Observed decreased target lesion revascularization (TLR) rates have potential for savings despite increased initial costs. The purpose of this study was to simulate a transition from BMS to DES over 5 years, evaluating the overall cost impact of that transition.
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Implementation of Drug-Eluting Stents for the
Methods: Florida state ambulatory databases were searched for patients undergoing SFA stenting in 2013 (Current Procedural Terminology codes 37226 and 37227). A model was developed to estimate the impact of progressive transition from BMS to DES over a 5-year horizon in this population. Cost estimates were determined from available cost-tocharge ratios. 2013 was the initial year for the model with each subsequent year based on the expected number of interventions per year. Up to one TLR per patient was assumed for the model. TLR rates for DES and other parameter estimates were based on pooled data from the literature. Institutional data were used to estimate that up to 48% of lesions would fit the instructions for use for the Zilver PTX, currently the only United States Food and Drug Administration-approved DES for peripheral interventions. Net budget impact was expressed as difference in total costs (primary stenting and reinterventions) for a scenario where BMS is progressively replaced by Zilver PTX compared to a scenario of BMS only. Multiple sensitivity analyses were performed on the base scenario.
Results: A total of 4107 peripheral interventions fit our study. Overall cost for these procedures in the Florida database was $51,362,142.00. In the base case, DES was introduced at a rate of 8% per year up to 48% at the end of the model. This resulted in an overall cost savings of $1,688,953.72 compared to the model with BMS alone. Net budget impact by year with DES vs BMS only is illustrated in the Fig, where a negative net budget impact indicates savings. Sensitivity analyses, including slower adoption of DES up to 24% at 5 years, a 20% increase in TLR rates per year for the DES, and a 10% reduction in TLR rates per year for BMS still resulted in a net savings. As long as the additional cost of a DES compared to BMS is less than $677, the DES model remains less expensive.
Conclusions: The adoption of drug eluting stents in lieu of traditional BMS can lead to significant cost savings in a single state system over a short time horizon.
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VESS23.
Long-Term Decline in Renal Function
University of Michigan Medical Center
Objectives: It is not clear whether endovascular repair of abdominal aortic aneurysms (EVAR) results in more decline in renal function over the long-term when compared to open repair (OR). We reviewed our experience with abdominal aortic aneurysm (AAA) repair to determine whether there was a significant difference in immediate postoperative and long-term renal outcomes between OR and EVAR.
Methods: A retrospective cohort study was conducted on all patients who underwent AAA repair between January 1993 and July 2013 at a tertiary referral hospital. Demographics, comorbidities, preoperative and postoperative laboratory values, morbidity, and mortality were collected. Patients with ruptured AAAs, preoperative hemodialysis, juxtarenal or suprarenal aneurysm origin, and no follow-up laboratory values were excluded. Preoperative, postoperative, 6-month, and yearly serum creatinine values were collected. Glomerular filtration rate (GFR) was calculated based on the Chronic Kidney Disease Epidemiology Collaboration equation. Acute kidney injury (AKI) was classified using the Kidney Disease: Improving Global Outcomes guidelines. D GFR was defined as preoperative GFR minus the GFR at each follow-up interval. Comparison was made between EVAR and OR groups using multivariate logistics for categoric data and linear regression for continuous variables. Results: During the study period, 769 infrarenal AAA repairs were performed at our institution; 675 repairs fit the inclusion criteria (315 OR and 360 EVARs). Mean age was 73.9 years, 79% were males, 78% were hypertensive, 18% were diabetic, and 31% had preoperative renal dysfunction defined as a GFR <60 mL/min. A multivariate logistic model to control for all variables found that OR had a 1.6-times greater chance of developing immediate postoperative AKI compared with EVAR (P ¼ .038). Hypertension and aneurysm size were also independent risk factors for developing AKI (P ¼ .012 and P ¼ .022, respectively). Using a linear regression model, we found a greater decline in GFR postoperatively in the EVAR group. This was significant starting at postoperative year 4 (Fig) . AKI and preoperative renal dysfunction were other independent risk factors for long-term decline in renal function.
Conclusions: Despite the deleterious effect of OR on immediate postoperative renal function, patients undergoing OR experience a slower decline in GFR over time compared to EVAR patients. The basis for this greater decline in renal function in EVAR patients is undefined but could relate to the need for postoperative EVAR surveillance. Studies comparing EVAR and OR may need longer follow-up to detect clinically significant differences in renal function.
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VESS24. Duplex Ultrasound Assessment and Outcomes of Renal Malperfusion Syndromes After Acute Aortic Dissection
Michael J. Osgood, Joshua Grimm, Christopher J. Abularrage, Ying Wei Lum, Diana Call, James H. Black III. Johns Hopkins Hospital, Baltimore, Md Objectives: Acute aortic dissection involving the renovisceral aorta may result in renal malperfusion. A lack of consensus exists regarding the management of renal malperfusion syndromes. We therefore sought to characterize the natural history of renal malperfusion in acute aortic dissection, identify ultrasound features predictive of renal failure, and assess the long-term result of malperfusion procedures.
Methods: Using institutional databases, we identified patients presenting with acute Stanford type A and B aortic dissections with involvement of the renovisceral aorta between 2004 and 2016. We collected demographics, radiographic data, including computed tomography and renal duplex scans, creatinine (Cr) levels, and clinical outcomes. Primary outcomes were overall mortality, progression to acute kidney injury (AKI; defined as increase in serum Cr of >50%), and peak and follow-up Cr levels. We further assessed the outcomes in patients who underwent a procedure to treat malperfusion (thoracic endovascular aortic repair, renal artery stenting, central aortic fenestration).
Results:
We identified 38 patients with acute dissection involving the renovisceral aorta. Mean follow-up was 5.8 years, mean age was 58.2, 74% were male, 45% had Stanford type A, and 55% had Stanford type B dissections. The true lumen supplied both renal arteries in 21%, the false lumen supplied both renal arteries in 8%, and the remaining 71% of patients had one renal artery supplied by each lumen. AKI developed in 71% of patients, 10.5% required dialysis, and 5% developed permanent dialysis dependence. Mean Cr at presentation was 1.6 mg/dL, mean peak Cr was 3.6, and mean follow-up Cr was 1.8. Development of AKI was correlated with higher peak initial Cr levels (4.2 vs 2.2; P ¼ .02) and higher mortality (22% vs 0%; P ¼ .04). Progression to AKI was associated with significantly lower end-diastolic velocity (EDV) measurements on renal duplex (17 vs 28 cm/s; P ¼ .01); however, peak systolic velocities (PSV) were not predictive. In follow-up, no kidneys developed atrophy when EDV was >30 cm/s. Intervention (10 of 38) was associated with lower follow-up Cr (0.88 vs 2.12; P ¼ .02), although there was no difference in progression to AKI, dialysis dependence, or mortality.
Conclusions: Development of AKI following acute aortic dissection of the visceral abdominal aorta is associated with higher mortality. Performing a renal malperfusion procedure did not significantly improve renal outcomes or overall survival, although the follow-up Cr in this group was lower. Renal malperfusion syndromes can be accurately predicted by EDV measurements on renal duplex ultrasound imaging.
Author Disclosures: C. J. Abularrage: Nothing to disclose; J. H. Black: Nothing to disclose; D. Call: Nothing to disclose; J. Grimm: Nothing to disclose; Y. Lum: Nothing to disclose; M. J. Osgood: Nothing to disclose. Objectives: Prior aortic surgery is a risk factor for increased morbidity following subsequent open aortic surgery. The purpose of this study was to evaluate the impact of prior aortic surgery on outcomes after subsequent multibranched endovascular repair (MBEVAR) of thoracoabdominal (TAAA) and pararenal aortic aneurysms (PRAA).
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Methods: From July 2005 to October 2016, 153 patients underwent elective endovascular repair of TAAA and PRAA using multibranched stent grafts. Data on demographics, operative repair, complications, and outcomes were collected prospectively.
Results: The mean age was 73 6 8 years, and 113 of 153 (74%) were men. Mean aneurysm diameter was 67 6 9 mm. Of 153 patients, 72 (47%) had undergone a prior aortic surgery before MBEVAR, 53 (74%) had prior open aortic surgery, 14 (19%) had prior endovascular aortic surgery, and 5 (7%) had both. There were no significant differences in age, sex, preoperative aneurysm diameter, or medical comorbidities (coronary artery disease, lung disease, diabetes mellitus, or hypertension) in patients who had previous aortic surgery compared to those without previous aortic surgery. Compared to those without previous aortic surgery, patients with previous aortic surgery had longer fluoroscopy times (116 6 51 vs 133 6 61 minutes; P ¼ .07) and procedural times (340 6 110 vs 375 6 110 minutes; P ¼ .12) during MBEVAR, but these did not reach statistical significance. Postoperative paraplegia developed in 12 of 153 patients (8%); this occurred in 3 of 72 of patients (4%) with previous aortic surgery compared to 9 of 81 (11%) without previous aortic surgery (P ¼ .14). Three of 153 patients (2%) had a postoperative stroke, and this was not different between the two groups. Median follow-up time was 3.0 years (interquartile range, 1.0-4.5 years) and did not differ between those with and without previous aortic surgery. Kaplan-Meier estimated 5-year freedom from aneurysmrelated mortality and overall mortality was 90% and 48%, respectively, and did not differ between the two groups (Fig 1, A and B) . There was also no difference in branch vessel occlusion or reintervention rates between the two groups. 
